Are Literature References Sufficient for Dose Recommendations? An FDA Case Study of Efavirenz and Rifampin

Authors :: DiGiacinto, Jennifer L.
Chan-Tack, Kirk M.
Robertson, Sarah M.
Reynolds, Kellie S.
Struble, Kimberly A.
Source :: Journal of Clinical Pharmacology. April 2008, Vol. 48 Issue 4, p518, 6 p.
Publication Year :: 2008
Abstract: Byline: Jennifer L. DiGiacinto, PharmD (Office of Clinical Pharmacology, Division IV, US Food and Drug Administration, Silver Spring, Maryland); Kirk M. Chan-Tack, MD (Office of New Drugs, Division of Anti-Viral [...]

Subjects :: United States. Food and Drug Administration
Medical research -- Case studies
Medicine, Experimental -- Case studies
Antiviral agents -- Dosage and administration -- Case studies
Drug therapy, Combination -- Case studies
Anti-HIV agents -- Dosage and administration -- Case studies
Antiparasitic agents -- Dosage and administration -- Case studies -- Labeling
Rifampin -- Dosage and administration -- Case studies
Health
Case studies
Labeling
Dosage and administration

Full Text Access

Tools